Journal: Vaccine
Lead Author: Desai et al.
Original date of publication: 07/22/2021
Link: https://pubmed.ncbi.nlm.nih.gov/34215453/
Keywords: adverse eventsAnaphylaxiscovid vaccinationmRNA
Full Author List: Aditya P Desai, Aryan P Desai, Gregory J Loomis
Lead Author: Desai et al.
Original date of publication: 07/22/2021
Link: https://pubmed.ncbi.nlm.nih.gov/34215453/
Summary Context
This study looks at rates of anaphylaxis post mRNA and finds a 2 to 7 times higher risk among people who already analylaxed previously.
Comments
Higher rates of anaphylaxis for people who had experienced it before, 2-7x the likelihood for that group post mRNA injection.
Abstract or Results, Key Passages
“It appeared that the relative incidence of anaphylaxis following administration of these COVID-19 vaccines was two and seven times higher for recipients with a prior history of allergies and/or anaphylaxis, respectively. This report provides valuable metrics to make evidence-based decisions for subjects with pre-existing allergic conditions receiving a COVID-19 mRNA vaccine.”
Keywords: adverse eventsAnaphylaxiscovid vaccinationmRNA
Full Author List: Aditya P Desai, Aryan P Desai, Gregory J Loomis
